PROPHYLACTIC ANTIBIOTICS PRIOR TO CESAREAN SECTION IN OBESE WOMEN

NCT ID: NCT01810354

Last Updated: 2014-07-24

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 58 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2013-04-30
• Study Completion Date: 2014-07-31

Brief Summary

Surgical site infections are common and a cause of major morbidity. They are also more common in obese women. Cesarean sections are the most common surgery performed in the United States, therefore pregnant women are being faced with this problem frequently. There is evidence to show that prophylactically administered antibiotics, cefazolin specifically, to obese women prior to cesarean section do not reach adequate concentrations in adipose tissue to prevent infection. The purpose of this study is to evaluate if an increased dose of cefazolin will attain adequate tissue concentration in obese women. Our hypothesis is that three grams of cefazolin given no more than 60 minutes prior to the start of a cesarean section in an obese (Body mass index (BMI) greater than or equal to 30) woman will attain adequate adipose tissue concentration compared to two grams of cefazolin.

Subjects will be selected if they are greater than 37 weeks gestation wiht a singleton pregnancy and require a cesarean section for any obstetrical indication. Women will be excluded if they have a suspected infection, have a multiple gestation, or have preexisting diabetes or hypertension with end organ damage. The subjects will be screened both by through the OR schedule as well as through the clinics. They will then be consented and enrolled by the primary investigator. Once enrolled the subjects will be randomized to receive either two grams or three grams of cefazolin as prophylactic antibiotics to be given no more than 60 minutes prior to the start of the surgery.

Two adipose tissue samples will be obtained at the time of surgery. The first at the start after skin incision and the second at the end prior to closure of the skin. There will also be a separate IV placed at the start of the procedure from which three blood draws can be collected. These three samples will be obtained at the start of the surgery but after antibiotic administration, at the time of the first adipose collection, and at the time of the second adipose collection. The samples will then be stored at -80 degrees and shipped to David P. Nicolau's lab in Hartford, CT for the tissue and serum analysis.

While the subjects are in the hospital recovering from their surgery, a chart review will be performed to determine if there are any infections occuring post-operatively. A telephone survey will be conducted six to eight weeks postpartum again assessing for any infectious complications after the cesarean section.

Conditions

Infection Prevention

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: PREVENTION
• Blinding Strategy: QUADRUPLE

Study Groups

Two grams cefazolin

Two grams of cefazolin will be given by intravenous bolus zero to 60 minutes prior to the start of the cesarean section.

Group Type: EXPERIMENTAL

Cefazolin

Intervention Type: DRUG

Three grams cefazolin

Three grams of cefazolin will be given by intravenous bolus zero to 60 minutes prior to the start of the cesarean section.

Group Type: ACTIVE_COMPARATOR

Cefazolin

Intervention Type: DRUG

Interventions

Cefazolin

Intervention Type: DRUG

Eligibility Criteria

Inclusion Criteria

• Obese - body mass index (BMI) calculated as weight (kg)/ [height (m2)]greater than or equal to 30 as determined at their first prenatal visit
• Gestational age of 37 0/7 weeks and greater
• Singleton Pregnancy
• Non-emergent cesarean section

Exclusion Criteria

• Known cephalosporin allergy
• Severe allergy to penicillin making cephalosporin use a contraindication
• Exposure to antibiotics in the preceding 7 days
• Need for emergent cesarean section
• Multiple gestations
• Suspected chorioamnionitis
• Pre-gestational diabetes
• Chronic hypertension with evidence of end organ damage

• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: Yes

Sponsors

Women and Infants Hospital of Rhode Island

OTHER

Sponsor Role: lead

Responsible Party

Lindsay Maggio,

Maternal-Fetal Medicine Fellow

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Lindsay Maggio, MD

Role: PRINCIPAL_INVESTIGATOR

Women & Infant's Hospital

Brenna Anderson, MD

Role: STUDY_DIRECTOR

Women & Infants Hospital

Locations

Women & Infants Hospital

Providence, Rhode Island, United States

Countries

United States

References

Maggio L, Nicolau DP, DaCosta M, Rouse DJ, Hughes BL. Cefazolin prophylaxis in obese women undergoing cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2015 May;125(5):1205-1210. doi: 10.1097/AOG.0000000000000789.

Reference Type: DERIVED

PMID: 25932849 (View on PubMed)

Other Identifiers

13-0004

Identifier Type: -

Identifier Source: org_study_id